Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 7, 2008

View Archived Issues

The low-molecular-weight thiol pantethine confers protection against cerebral malaria

Shigella gastroenteritis vaccine immunogenic in phase I study

Salsalate reduces glycemia in obese subjects

ReNeuron schedules meeting with FDA to resolve IND hold for ReN-001

Penwest announces results of a phase IIa clinical study of nalbuphine ER

Positive results reported for memantine once-daily formulation study

Statistical significance achieved in phase III studies for Puricase in gout

Patient recruitment completed in phase IIa clinical trial of KUR-212 for skin grafting

FDA extends PDUFA action date for GSK's Requip XL for Parkinson's disease

Generex selects 72 clinical centers to participate in phase III study of Oral-lyn

Vaxine completes recruitment for phase I/II clinical trial of influenza vaccine

mtm Laboratories launches Cervatec assay for cervical cancer

GTC reports data from a pivotal study of ATryn for hereditary antithrombin deficiency

Recent patents report new therapeutic agents for obesity and lipoprotein disorders

Epistem and AstraZeneca report results from preliminary study of human hair biomarker technology

FDA supports favorable risk-benefit profile for Luitpold's Injectafer

Novel agents for psychological disorders disclosed in recent patent literature

Recent AstraZeneca patent describes novel antiarrhythmia agents

Promising antitumor effects with novel anti-HAAH antibody in preclinical studies

TorreyPines reports results from phase I clinical trial of tezampanel for chronic pain

Immunomedics announces results from phase I/II clinical trial of veltuzumab

Astex receives IND approval for Hsp90 inhibitor AT-13387

7TM Pharma selects new preclinical candidate for obesity and type 2 diabetes

Biovitrum and Symphogen complete phase I recombinant polyclonal antibody trial

Intercell's HCV vaccine meets primary endpoints in phase II clinical studies

Positive results reported from Nymox's U.S. study of NX-1207 for BPH

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....